We are an AI-immunologyTM platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases.

We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can harness its powers through novel immunotherapies. Our scalable AI-immunology core technology enables broad applicability across diseases with immunological components. With deep insights into the biological processes of the immune system, we bridge technology, engineering expertise and drug development know-how to bring novel immunotherapies to patients.

Technology

Technology

Our current proprietary AI-immunology platform technologies PIONEERTM, EDENTM, and RAVENTM are trained to translate vast amounts of data into a deep understanding of biological processes in the human body to rapidly and cost effectively design and develop novel immunotherapies.

link to technology page

Team

Team

With some of the most talented bioinformaticians, scientists, and executives in the field, we are committed to bringing the vision for better global health to reality. Through our deep understanding of the immune system and AI capabilities, we hope to redefine discovery and development of immunotherapies and impact the lives of patients.

link to leadership page

Pipeline

Pipeline

Based on our state-of-the-art AI platforms, we are advancing a robust product pipeline in immuno-oncology and infectious diseases with primary focus on drug discovery and early drug development, building on a simple and scalable business model.

link to pipeline page
View all news

Latest News